Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAOA | P21397 | 3/20 | 0.37 |
| ▸ | MIF | P14174 | 3/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | TNF | P01375 | 2/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19428057 | 0.87 | MIF (0.40) | MEN1KMT2AKDM4EMAOAMIF | |
| SCHEMBL19293332 | 0.86 | KDM4E (0.39) | MEN1KMT2AKDM4EMAOAMIF | |
| SCHEMBL19067400 | 0.83 | KDM4E (0.44) | MEN1KMT2AKDM4EMAOAMIF | |
| SCHEMBL21784415 | 0.83 | MEN1 (0.39) | MEN1KMT2AKDM4EMAOAMIF | |
| SCHEMBL22421787 | 0.79 | KDM4E (0.41) | MEN1KMT2AKDM4EMAOAMIF | |
| SCHEMBL6724258 | 0.74 | CES1 (0.46) | MEN1KMT2AKDM4EMAOAMAOB | |
| SCHEMBL20687370 | 0.72 | MAPT (0.40) | MEN1KMT2AKDM4EMAOAMIF | |
| SCHEMBL2453186 | 0.71 | MIF (0.59) | MEN1KMT2AKDM4EMAOAMIF | |
| Fluorene SCHEMBL21874615 | 0.71 | MAOA (0.52) | MEN1KMT2AKDM4EMAOACHRM1 | |
| Fluorene SCHEMBL3334524 | 0.68 | MAOA (0.54) | MEN1KMT2AKDM4EMAOAMIF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329092-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-11744145-B2 | Organic compound and organic electroluminescent device comprising the same | LG DISPLAY CO., LTD. (KR) | 2023-08-29 | — | — | US | disclosed |
| US-20230048456-A1 | ORGANIC LIGHT-EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER THEREOF | LT MATERIALS CO., LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| US-20210317069-A1 | ARYLAMINE COMPOUND, HOLE-TRANSPORT LAYER MATERIAL, HOLE-INJECTION LAYER MATERIAL, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPARATUS, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20200321525-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | MATERIAL SCIENCE CO., LTD. (KR) | 2020-10-08 | — | — | US | disclosed |
| EP-3377496-B1 | IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES | BRISTOL MYERS SQUIBB CO (US) | 2020-09-16 | — | — | EP | disclosed |
| US-20200212301-A1 | SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| US-20200144506-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | MATERIAL SCIENCE CO., LTD. (KR) | 2020-05-07 | — | — | US | disclosed |
| US-10463639-B2 | Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction | INSTYTUT BIOCHEMII I BIOFIZYKI PAN (PL) | 2019-11-05 | — | — | US | disclosed |
| WO-2018089402-A1 | TRICYCLIC SULFONES AS ROR GAMMA MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200321525-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | OR10J3, OR51E2, ORC3 | MEN1 2380/4885KMT2A 1074/4885KDM4E 1082/4885 |
| US-20200212301-A1 | SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES | SELE, KCNB2, SCNN1B | MEN1 1092/4885KMT2A 3411/4885KDM4E 4520/4885 |
| US-20230329092-A1 | MATERIALS FOR ELECTRONIC DEVICES | SOD1, GPX1, EFNA1 | MEN1 488/4885KMT2A 2074/4885KDM4E 2946/4885 |
| US-10463639-B2 | Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction | CFTR, TMEM161A, TCOF1 | MEN1 4030/4885KMT2A 2876/4885KDM4E 3564/4885 |
| US-20210317069-A1 | ARYLAMINE COMPOUND, HOLE-TRANSPORT LAYER MATERIAL, HOLE-INJECTION LAYER MATERIAL, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPARATUS, AND LIGHTING DEVICE | AHR, ARNT, AAAS | MEN1 3965/4885KMT2A 2032/4885KDM4E 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.